Jordan Elm

Jordan Elm

Medical University of South Carolina

H-index: 40

North America-United States

About Jordan Elm

Jordan Elm, With an exceptional h-index of 40 and a recent h-index of 33 (since 2020), a distinguished researcher at Medical University of South Carolina, specializes in the field of Biostatistics, Clinical Trials.

His recent articles reflect a diverse array of research interests and contributions to the field:

Biomarkers of Atrial Cardiopathy and Outcomes After Cryptogenic Stroke: The ARCADIA Trial

Subarachnoid Hemorrhage Trials: Cutting, Sliding, or Keeping mRS Scores and WFNS Grades

Desirability of Outcome Ranking for Status Epilepticus: A Benefit-Risk Approach to Design and Analyses of Clinical SE Trials

An Expected Score Approach to Ordinal Outcomes in a Bayesian, Response Adaptive, Randomized Trial

Individual differences in response to transcranial direct current stimulation with language therapy in subacute stroke

Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy

Optimal randomization designs for large multicenter clinical trials: from the National Institutes of Health Stroke Trials Network funded by National Institutes of Health …

Transcranial direct-current stimulation in subacute aphasia: a randomized controlled trial

Jordan Elm Information

University

Position

Associate Professor of Biostatistics

Citations(all)

6711

Citations(since 2020)

4996

Cited By

3462

hIndex(all)

40

hIndex(since 2020)

33

i10Index(all)

75

i10Index(since 2020)

69

Email

University Profile Page

Google Scholar

Jordan Elm Skills & Research Interests

Biostatistics

Clinical Trials

Top articles of Jordan Elm

Biomarkers of Atrial Cardiopathy and Outcomes After Cryptogenic Stroke: The ARCADIA Trial

Stroke

2024/2

Subarachnoid Hemorrhage Trials: Cutting, Sliding, or Keeping mRS Scores and WFNS Grades

2024/1/18

Desirability of Outcome Ranking for Status Epilepticus: A Benefit-Risk Approach to Design and Analyses of Clinical SE Trials

Neurology

2023/10/17

An Expected Score Approach to Ordinal Outcomes in a Bayesian, Response Adaptive, Randomized Trial

Statistics in biopharmaceutical research

2023/10/2

Individual differences in response to transcranial direct current stimulation with language therapy in subacute stroke

Neurorehabilitation and neural repair

2023/8

Jordan Elm
Jordan Elm

H-Index: 25

Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy

Frontiers in Neurology

2023/7/18

Jordan Elm
Jordan Elm

H-Index: 25

Optimal randomization designs for large multicenter clinical trials: from the National Institutes of Health Stroke Trials Network funded by National Institutes of Health …

2023/7

Transcranial direct-current stimulation in subacute aphasia: a randomized controlled trial

Stroke

2023/4

Why ketamine

2023/4/1

Jordan Elm
Jordan Elm

H-Index: 25

James Chamberlain
James Chamberlain

H-Index: 4

Recruitment in acute stroke trials: challenges and potential solutions

2023/2

Design Considerations for Factorial Adaptive Multi-Arm Multi-Stage (FAST) Clinical Trials

arXiv preprint arXiv:2310.12830

2023/10/19

Electroencephalographic seizures in emergency department patients after treatment for convulsive status epilepticus

Journal of Clinical Neurophysiology

2022/9/1

Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): protocol for a phase III, double-blind, randomized, placebo-controlled trial

International journal of stroke

2022/8

A feasibility study of objective outcome measures used in clinical trials of freezing of gait

Pilot and Feasibility Studies

2022/7/4

Abstract WP7: Critical Importance Of Enrollment Hours For Successful Recruitment In Acute Stroke Trials

Stroke

2022/2

Individualized response to semantic versus phonological aphasia therapies in stroke

Brain Communications

2021

Speech entrainment for aphasia recovery (SpARc) phase II trial design

Contemporary Clinical Trials Communications

2021/12/1

Jordan Elm
Jordan Elm

H-Index: 25

Leonardo Bonilha
Leonardo Bonilha

H-Index: 42

Cilostazol for secondary stroke prevention: history, evidence, limitations, and possibilities

2021/10

The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: rationale and methods

2021/10

See List of Professors in Jordan Elm University(Medical University of South Carolina)